JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

Search

Quanterix Corp

Închisă

SectorSănătate

3.16 -2.77

Rezumat

Modificarea prețului

24h

Curent

Minim

3.03

Maxim

3.25

Indicatori cheie

By Trading Economics

Venit

10M

-23M

Vânzări

3.7M

44M

Marjă de profit

-52.712

Angajați

450

EBITDA

15M

-17M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+68.71% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-141M

155M

Deschiderea anterioară

5.93

Închiderea anterioară

3.16

Sentimentul știrilor

By Acuity

50%

50%

178 / 348 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

24 apr. 2026, 00:00 UTC

Câștiguri

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

24 apr. 2026, 00:00 UTC

Câștiguri

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

23 apr. 2026, 23:47 UTC

Market Talk

Gold Edges Lower Amid Ongoing Concerns Over Higher Inflation -- Market Talk

23 apr. 2026, 23:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 apr. 2026, 23:43 UTC

Market Talk

Global Equities Roundup: Market Talk

23 apr. 2026, 23:43 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over U.S.-Iran Conflict -- Market Talk

23 apr. 2026, 23:13 UTC

Achiziții, Fuziuni, Preluări

Trump on Spirit Airlines: 'I Think We'd Just Buy It' -- Update

23 apr. 2026, 22:33 UTC

Câștiguri

Intel Shares Jump 20% as AI Agents Drive Big Growth -- WSJ

23 apr. 2026, 22:17 UTC

Câștiguri

PLS Executed Offtake Agreement With Ronbay

23 apr. 2026, 22:17 UTC

Câștiguri

PLS Secured Up to A$38.1M in Australia Government ARENA Grant Funding

23 apr. 2026, 22:16 UTC

Câștiguri

PLS Commences Commissioning of Midstream Demonstration Plant

23 apr. 2026, 22:15 UTC

Câștiguri

PLS Group Reaffirms FY26 Guidance for All Metrics

23 apr. 2026, 22:14 UTC

Câștiguri

PLS Group 3Q Cash Margin From Operations A$461M at March 31

23 apr. 2026, 22:14 UTC

Câștiguri

PLS Group 3Q Cash Balance A$1.455 Billion at March 31

23 apr. 2026, 22:13 UTC

Câștiguri

PLS Group 3Q Unit Operating Cost A$733/Ton CIF, Up 2% on 2Q

23 apr. 2026, 22:12 UTC

Câștiguri

Correct: PLS Group 3Q Unit Operating Cost A$520/Ton FOB, Down 11% on 2Q

23 apr. 2026, 22:12 UTC

Câștiguri

PLS Group 3Q Unit Operating Cost US$520/Ton FOB, Down 11% on 2Q

23 apr. 2026, 22:11 UTC

Câștiguri

PLS Group 3Q Realized Price US$1,867/Ton, Up 61% on 2Q

23 apr. 2026, 22:10 UTC

Câștiguri

PLS Group 3Q Revenue A$567,000, Up 52% on 2Q

23 apr. 2026, 22:09 UTC

Câștiguri

PLS Group 3Q Sales 195,700 Tons, Down 16% on 2Q

23 apr. 2026, 22:08 UTC

Câștiguri

PLS Group 3Q Production 232,400 Tons, Up 12% on 2Q

23 apr. 2026, 22:04 UTC

Câștiguri

Intel Sales Rise 7% as AI Agents Drive Growth -- WSJ

23 apr. 2026, 21:56 UTC

Market Talk
Câștiguri

Intel Points to Growing Role of CPUs Amid AI Shifts -- Market Talk

23 apr. 2026, 21:48 UTC

Achiziții, Fuziuni, Preluări

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

23 apr. 2026, 21:27 UTC

Câștiguri

Intel CFO: All Demand Signals Point to Growing Role of CPUs in AI Era

23 apr. 2026, 21:25 UTC

Câștiguri

Intel CFO Expects Factories to Continue Increasing Supply in 3Q, 4Q, but at More Measured Pace Than Previously Expected

23 apr. 2026, 21:24 UTC

Câștiguri

SAP Stock Rebounds From Software Slaughter. The Cloud Boosted Europe's Tech Titan. -- Barrons.com

23 apr. 2026, 21:24 UTC

Câștiguri

Blackstone Stock Falls After Earnings. Private Credit Remains in Focus. -- Barrons.com

23 apr. 2026, 21:21 UTC

Câștiguri

Intel to Look for Unconventional Way to Boost Manufacturing Capacity Through Musk's Terafab Project, CEO Says

23 apr. 2026, 21:21 UTC

Câștiguri

Intel CEO: He, Elon Musk Believe Global Semiconductor Supply Isn't Keeping Up With Accelerating Demand

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

68.71% sus

Prognoză pe 12 luni

Medie 5.5 USD  68.71%

Maxim 7 USD

Minim 4 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

178 / 348 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat